DE602004018634D1 - Carbonsäureverbindung und arzneimittel welches diese enthält - Google Patents

Carbonsäureverbindung und arzneimittel welches diese enthält

Info

Publication number
DE602004018634D1
DE602004018634D1 DE602004018634T DE602004018634T DE602004018634D1 DE 602004018634 D1 DE602004018634 D1 DE 602004018634D1 DE 602004018634 T DE602004018634 T DE 602004018634T DE 602004018634 T DE602004018634 T DE 602004018634T DE 602004018634 D1 DE602004018634 D1 DE 602004018634D1
Authority
DE
Germany
Prior art keywords
carboxylic acid
acid compound
medicines containing
diabetes
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004018634T
Other languages
English (en)
Inventor
Keisuke Inoue
Tsutomu Toma
Takahiro Kitamura
Yukiyoshi Yamazaki
Tetsuya Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of DE602004018634D1 publication Critical patent/DE602004018634D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602004018634T 2003-05-23 2004-05-21 Carbonsäureverbindung und arzneimittel welches diese enthält Expired - Fee Related DE602004018634D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47273703P 2003-05-23 2003-05-23
JP2003154372 2003-05-30
PCT/JP2004/007316 WO2004103946A1 (ja) 2003-05-23 2004-05-21 カルボン酸化合物及びこれを含有する医薬

Publications (1)

Publication Number Publication Date
DE602004018634D1 true DE602004018634D1 (de) 2009-02-05

Family

ID=33479004

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018634T Expired - Fee Related DE602004018634D1 (de) 2003-05-23 2004-05-21 Carbonsäureverbindung und arzneimittel welches diese enthält

Country Status (14)

Country Link
EP (1) EP1627866B1 (de)
KR (1) KR20060031605A (de)
AT (1) ATE418532T1 (de)
AU (1) AU2004241224A1 (de)
BR (1) BRPI0411136A (de)
CA (1) CA2526637A1 (de)
DE (1) DE602004018634D1 (de)
EA (1) EA010020B1 (de)
IL (1) IL171993A0 (de)
MX (1) MXPA05012612A (de)
MY (1) MY132415A (de)
NO (1) NO20056135L (de)
NZ (1) NZ544155A (de)
WO (1) WO2004103946A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1752145A1 (de) * 2004-06-01 2007-02-14 Kowa Company Ltd. Therapeutisches mittel gegen hyperlipämie und therapeutisches mittel gegen diabetes
WO2006118187A1 (ja) * 2005-04-28 2006-11-09 Ube Industries, Ltd. ２，２－ジクロロ－１２－（４－ハロフェニル）ドデカン酸塩及びその製造中間体の製法
US20100261933A1 (en) 2006-03-31 2010-10-14 Kowa Company, Ltd. Method for preparing carboxylic acid compound
WO2009038204A1 (ja) * 2007-09-17 2009-03-26 Pharma Frontier Co., Ltd. 新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするｇタンパク質共役型レセプター作動剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1473033A1 (de) * 2002-01-16 2004-11-03 Kowa Company Ltd. Medizinische zusammensetzung mit 2,2-dichloro-12-(4-chlorphenyl)dodecansäure

Also Published As

Publication number Publication date
ATE418532T1 (de) 2009-01-15
IL171993A0 (en) 2009-02-11
EP1627866B1 (de) 2008-12-24
MXPA05012612A (es) 2006-02-22
KR20060031605A (ko) 2006-04-12
CA2526637A1 (en) 2004-12-02
EP1627866A4 (de) 2006-10-04
AU2004241224A1 (en) 2004-12-02
NZ544155A (en) 2008-03-28
NO20056135L (no) 2005-12-22
EA200501853A1 (ru) 2006-06-30
EA010020B1 (ru) 2008-06-30
WO2004103946A1 (ja) 2004-12-02
MY132415A (en) 2007-10-31
BRPI0411136A (pt) 2006-07-18
EP1627866A1 (de) 2006-02-22

Similar Documents

Publication Publication Date Title
DE60009929D1 (de) Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
CA2474578A1 (en) Novel pyridin- and pyrimidin-derivatives
ATE264311T1 (de) Verbindungen zur behandlung und vorsorge bei diabetes
EP1726580A4 (de) Aminophenylpropansäurederivat
DE69634664D1 (de) Heterocyclische carbonsäurederivate und diese enthaltende arzneimittel
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
IL171993A0 (en) Carboxylic acid compound and medicine containing the same
IL159412A0 (en) A synergistic pharmaceutical combination for the prevention or treatment of diabetes
EP1147772A4 (de) Medizinische zusammensetzungen zur behandlung der vorhof-fibrillation
BR0209735A (pt) Derivados heterocìclicos e uso medicinal destes
MA27738A1 (fr) Dérivés de cycloalkyle 1,3-substitués contenant des groupes acides, principalement hétérocycliques, procédés de préparation correspondants et utilisation desdits dérivés en tant que médicaments
TW200503681A (en) Carboxylic compound and medicine comprising the same
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
EP1666472A4 (de) Phenylessigsäurederivat, verfahren zu dessen herstellung und verwendung
IL159841A0 (en) Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
PL301783A1 (en) Nonateraenic acid derivative, method of obtaining such derivative and pharmaceutical compositions containing it
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
TH71668A (th) สารประกอบคาร์บอกซิลิก และสารที่ใช้รักษาโรคซึ่งประกอบด้วยสารประกอบนี้
WO2003063858A3 (fr) Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires
EP1484316A4 (de) Neue propionsäurederivate
NO20045223L (no) Orto-substituerte benzosyrederivater for behandling av insulinresistens
NO20042881L (no) Substituerte cykloheksan-derivater
TH64466A (th) อนุพันธ์เฮเทอโรไซคลิกใหม่ และการใช้ทางเภสัชกรรมของอนุพันธ์

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee